Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dare Bioscience (DARE) Non-cash Items (2016 - 2017)

Historic Non-cash Items for Dare Bioscience (DARE) over the last 5 years, with Q3 2017 value amounting to $545640.0.

  • Dare Bioscience's Non-cash Items fell 6631.85% to $545640.0 in Q3 2017 from the same period last year, while for Sep 2017 it was $545640.0, marking a year-over-year decrease of 6631.85%. This contributed to the annual value of $1.6 million for FY2016, which is 6326.34% up from last year.
  • Latest data reveals that Dare Bioscience reported Non-cash Items of $545640.0 as of Q3 2017, which was down 6631.85% from $220497.0 recorded in Q2 2017.
  • Dare Bioscience's Non-cash Items' 5-year high stood at $3.2 million during Q1 2014, with a 5-year trough of $7000.0 in Q2 2016.
  • For the 5-year period, Dare Bioscience's Non-cash Items averaged around $942474.3, with its median value being $655945.0 (2014).
  • Per our database at Business Quant, Dare Bioscience's Non-cash Items soared by 3833198.63% in 2014 and then crashed by 9897.02% in 2016.
  • Over the past 5 years, Dare Bioscience's Non-cash Items (Quarter) stood at $7028.0 in 2013, then skyrocketed by 38331.99% to $2.7 million in 2014, then plummeted by 62.92% to $1.0 million in 2015, then soared by 63.26% to $1.6 million in 2016, then crashed by 66.63% to $545640.0 in 2017.
  • Its last three reported values are $545640.0 in Q3 2017, $220497.0 for Q2 2017, and $1.6 million during Q4 2016.